Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

60.65
Delayed Data
As of Dec 02
 +2.11 / +3.60%
Today’s Change
26.80
Today|||52-Week Range
70.92
+34.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$703.0M

Company Description

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which develops, manufactures and markets branded and generic prescription pharmaceuticals. The company's areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. It has two pharmaceutical manufacturing facilities located in Baudette, Minnesota, which produces oral solid dose products, as well as liquids and topicals, narcotics, and potent products. ANI Pharmaceuticals was founded on August 29, 1996 and is headquartered in Baudette, MN.

Contact Information

ANI Pharmaceuticals, Inc.
210 Main Street West
Baudette Minnesota 56623
P:(218) 634-3500
Investor Relations:

Employees

Shareholders

Other institutional35.86%
Individual stakeholders32.60%
Mutual fund holders22.45%

Top Executives

Arthur S. PrzybylPresident, Chief Executive Officer & Director
James G. MarkenVice President-Operations
Stephen P. CareyChief Financial Officer & Vice President
Rob W. SchrepferVice President-New Business Development
David J. SullivanVice President-Quality Operations